Antiverse is a biotechnology company specializing in the development of innovative therapeutic solutions through its proprietary platform that leverages artificial intelligence and machine learning. The company focuses on creating high-quality antibody candidates for various diseases, aiming to accelerate the drug discovery process. Antiverse's technology enables rapid identification and optimization of antibodies, enhancing the efficiency of therapeutic development in the pharmaceutical industry.